| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |